DERMA PHARM A/S: Financial statements 2021
CVR: 89453119
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
DERMA PHARM A/S (CVR 89453119) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 70,656,820 and a net result of DKK 7,227,010 compared with DKK 11,970,764 the year before. That is a decrease of 7.2% compared with the year before. Equity in the 2021 report amounted to DKK 39,606,648. The solvency ratio was 40.7%. The company had 115 employees in the financial year.
- Gross Profit
- DKK 70,656,820
- Profit/Loss
- DKK 7,227,010
- Equity
- DKK 39,606,648
- Total Assets
- DKK 97,383,921
- Employees
- 115
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 70.7 mio. | 7.2 mio. | 39.6 mio. | 115 |
| 2020 | - | 76.2 mio. | 12 mio. | 40.5 mio. | 108 |
| 2019 | - | 63.5 mio. | 6.1 mio. | 32.6 mio. | 105 |
| 2018 | - | 52.4 mio. | 4.6 mio. | 30.7 mio. | 91 |
| 2017 | - | 47.6 mio. | 8.6 mio. | 31 mio. | 71 |
Official annual report
Find more companies like DERMA PHARM A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
DERMA PHARM A/S has published its annual report for 2020. Gross profit came to DKK 76,154,516, and the net result was DKK 11,970,764.
About DERMA PHARM A/S
DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Mikkel Egelund Jensen and Peter Bogh. The board consists of Jean-Yves Paul Etienne Desmottes (chair), Magdalena Jurkiewicz, Marie Anne Louise Bozec and Massimiliano Costantini. The company is owned by DERMAPHARM HOLDING A/S. The company has 138 employees (2026). In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity in the 2025 report amounted to DKK 78,142,000.